Diethenofencarb

Diethenofencarb

SCHEMBL29467779

CCOc1ccc(NC(=O)OC(C)C)cc1OCC.COC(=O)Nc1nc2ccccc2[nH]1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.61
▸ MEN1 O00255 2/20 0.61
▸ KMT2A Q03164 2/20 0.61
▸ HTT P42858 2/20 0.61
▸ POLB P06746 1/20 0.61
▸ TUBB4A P04350 4/20 0.51
▸ TUBB P07437 4/20 0.51
▸ TUBA3C P0DPH7 4/20 0.51
▸ TUBA1B P68363 4/20 0.51
▸ TUBA4A P68366 4/20 0.51
▸ TUBB4B P68371 4/20 0.51
▸ TUBB3 Q13509 4/20 0.51
▸ TUBB2A Q13885 4/20 0.51
▸ TUBB8 Q3ZCM7 4/20 0.51
▸ TUBA3E Q6PEY2 4/20 0.51
▸ TUBA1A Q71U36 4/20 0.51
▸ TUBA1C Q9BQE3 4/20 0.51
▸ TUBB6 Q9BUF5 4/20 0.51
▸ TUBB2B Q9BVA1 4/20 0.51
▸ TUBB1 Q9H4B7 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethenofencarb SCHEMBL9055854 1.00 SMN1; SMN2 (0.61) SMN1; SMN2MEN1KMT2AHTTPOLB
Diethenofencarb SCHEMBL9055860 0.81 HPSE (0.51) SMN1; SMN2MEN1KMT2AHTTPOLB
SCHEMBL204300 0.81 TUBB4A (0.70) SMN1; SMN2MEN1KMT2AHTTTUBB4A
Diethenofencarb SCHEMBL22967 0.79 KDM4E (0.56) SMN1; SMN2KMT2AHTTMAPTLMNA
Carbendazim SCHEMBL8427009 0.76 LMNA (0.71) SMN1; SMN2MEN1KMT2AHTTMAPT
Carbendazim SCHEMBL21051 0.76 LMNA (0.71) SMN1; SMN2MEN1KMT2AHTTMAPT
Carbendazim SCHEMBL29357746 0.76 LMNA (0.71) SMN1; SMN2MEN1KMT2AHTTMAPT
Diethenofencarb SCHEMBL5310182 0.76 KMT2A (0.51) SMN1; SMN2MEN1KMT2AMAPTLMNA
Carbendazim SCHEMBL8716640 0.75 LMNA (0.69) SMN1; SMN2MEN1KMT2AHTTMAPT
Carbendazim SCHEMBL74664 0.75 LMNA (0.69) SMN1; SMN2MEN1KMT2AHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025042364-A1 A DELAY-DOPPLER IMPULSE-BASED SENSING AND COMMUNICATION METHOD ISTANBUL MEDIPOL UNIVERSITESI TEKNOLOJI TRANSFER OFISI ANONIM SIRKETI (TR) 2025-02-27 — — WO claimed
WO-2025010213-A2 MEDICAL CUTTING AND DRILL DEVICES HAVING STATIC COMPONENTS, RETRACTABLE SHEATHS, SENSORS, NAVIGATION COMPONENTS, WORKING BLADE BODIES, RAILS, STRUTS, CHANNELS FOR FLUID AND GAS FLOW, HAND-PIECE, ROBOTIC ARM ATTACHMENT CAPABILITIES, COMPUTING DEVICES, AND ASSOCIATED FEEDBACKS AND OUTPUTS Innovations 4 Surgery, LLC (US) 2025-01-09 — — WO claimed
WO-2024243337-A2 SUPERSONIC JET CURTAINS FOR CONTROL OF MOMENTS AND FORCES ON AIRCRAFT ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2024-11-28 — — WO claimed
US-20260132293-A1 INK-REPELLENT MEMBER, METHOD OF PRODUCING INK-REPELLENT MEMBER, INK JET HEAD, AND METHOD OF PRODUCING ARTICLE CANON KK (JP) 2026-05-14 — — US disclosed
EP-4736334-A1 METASURFACE DESIGN AND PLACEMENT Microsoft Technology Licensing, LLC (US) 2026-05-06 — — EP disclosed
EP-4736075-A2 MACHINE LEARNING BASED SYSTEM AND METHOD FOR BUDGET MANAGEMENT Insight Systems, Inc. (US) 2026-05-06 — — EP disclosed
EP-4719223-A2 DEVICES, SYSTEM AND METHODS FOR APPLYING MULTIPLE CLIPS TO TISSUE Intuitive Surgical Operations, Inc. (US) 2026-04-08 — — EP disclosed
EP-4716988-A1 A METHOD OF MANUFACTURING AN ACTIVE LAYER FOR A TRIBOELECTRIC NANOGENERATOR (TENG) Integrated Graphene Holding Limited (GB) 2026-04-01 — — EP disclosed
EP-4709421-A2 B. BURGDORFERI PEPTIDOGLYCAN ANTIBODIES AND USES THEREOF Virginia Tech Intellectual Properties, Inc. (US) 2026-03-18 — — EP disclosed
EP-4695556-A1 COUNTERTOP FREE-POSITIONING WIRELESS CHARGING DEVICE Aira, Inc. (US) 2026-02-18 — — EP disclosed
EP-4652196-A1 NEUROPILIN-1-PEPTIDE BASED ANTIBODY, HIGHLITING NEW EPITOPE ASSOCIATED TO GLYCOSAMINOGLYCAN-MODIFIED NEUROPILIN-1 AND METHODS OF USE THEREOF Theranovir (FR) 2025-11-26 — — EP disclosed
US-20220372293-A1 SELF-HEALING COMPOSITIONS FOR USE IN MEDICAL TRAINING SIMULATORS AND MANNEQUINS RAJAGOPALAN SUMITRA (CA) 2022-11-24 — — US disclosed
EP-4069823-A1 METHOD AND KIT FOR CELL GROWTH Precision Cancer Technologies Inc. (CA) 2022-10-12 — — EP disclosed
US-11440862-B2 Solvent composition, cleaning method, method of forming a coating film, heat transfer fluid, and heat cycle system AGC Inc. (JP) 2022-09-13 — — US disclosed
US-11427521-B2 Solvent composition, cleaning method, method of forming a coating film, heat transfer fluid, and heat cycle system AGC Inc. (JP) 2022-08-30 — — US disclosed
US-20220153666-A9 SOLVENT COMPOSITION, CLEANING METHOD, METHOD OF FORMING A COATING FILM, HEAT TRANSFER FLUID, AND HEAT CYCLE SYSTEM AGC Inc. (JP) 2022-05-19 — — US disclosed
CN-114423562-A Double-acting friction stir spot welding device and method for operating double-acting friction stir spot welding device 川崎重工业株式会社 2022-04-29 — — CN disclosed
EP-3985425-A1 COATING COMPOSITION FOR ENDOSCOPE, LUBRICATING MEMBER FOR ENDOSCOPE, PRODUCTION METHOD FOR LUBRICATING MEMBER FOR ENDOSCOPE, FLEXIBLE TUBE FOR ENDOSCOPE, AND ENDOSCOPE FUJIFILM Corporation (JP) 2022-04-20 — — EP disclosed
US-20220054717-A1 ENDOSCOPIC COATING COMPOSITION, ENDOSCOPIC LUBRICATING MEMBER, METHOD FOR PRODUCING ENDOSCOPIC LUBRICATING MEMBER, ENDOSCOPIC FLEXIBLE TUBE, AND ENDOSCOPE FUJIFILM CORPORATION (JP) 2022-02-24 — — US disclosed
US-11254824-B2 Solvent composition, cleaning method, method for producing substrate with coating film, and heat transfer fluid AGC Inc. (JP) 2022-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132293-A1 INK-REPELLENT MEMBER, METHOD OF PRODUCING INK-REPELLENT MEMBER, INK JET HEAD, AND METHOD OF PRODUCING ARTICLE ATM, ING2, MLLT3 SMN1; SMN2 770/4885MEN1 2572/4885KMT2A 1485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback